HealthStream Company Profile (NASDAQ:HSTM)

HealthStream trades on the NASDAQ under the ticker symbol "HSTM."

HealthStream, Inc. (NASDAQ:HSTM) posted its quarterly earnings results on Monday, July, 24th. The company reported $0.08 EPS for the quarter, topping the Zacks' consensus estimate of $0.04 by $0.04. The business earned $61.48 million during the quarter, compared to the consensus estimate of $61.36 million. HealthStream had a return on equity of 2.27% and a net margin of 1.85%. The company's revenue for the quarter was up 12.2% compared to the same quarter last year. During the same period last year, the firm earned $0.04 earnings per share. View HealthStream's Earnings History.

HealthStream is scheduled to release their next quarterly earnings announcement on Tuesday, October, 31st 2017. View Earnings Estimates for HealthStream.

6 equities research analysts have issued 12 month price objectives for HealthStream's shares. Their predictions range from $19.00 to $30.00. On average, they expect HealthStream's share price to reach $25.17 in the next twelve months. View Analyst Ratings for HealthStream.

Here are some recent quotes from research analysts about HealthStream stock:

• 1. According to Zacks Investment Research, "Healthstream Inc. is pioneering a Web-based solution to meet the training and education needs of the healthcare industry utilizing our proprietary system. Through strategic relationships with medical institutions and commercial organizations, the company has amassed hours of training and education courses. The company distributes hours of these courses online to allied healthcare professionals, nurses, doctors and other healthcare workers. " (7/26/2017)
• 2. Needham & Company LLC analysts commented, "HSTM reported 4Q revenue/EPS results below our estimates as both Workforce Solutions and PE segments came in below our estimates. Although HSTM's 4Q conference call highlighted good sales momentum across all segments, product transitions and implementation bottlenecks from 2H16 should linger into FY17 and sales of its resuscitation product are expected to slow. Subscriber growth exceeded expectations, while ARPU was flat Y/Y but should grow again in FY17. Initial FY17 guidance fell in line with our 12% growth estimate, but we find the mix of lower WF growth but higher PE growth to be mildly disappointing. We are optimistic on the company's product roadmap after management announced a number of new product innovations and believe the combination of organic and inorganic products can accelerate revenue growth into FY18." (2/23/2017)
• 3. Cantor Fitzgerald analysts commented, "After the close on Tuesday, February 21, HealthStream reported 4Q16 results that were below expectations. However, the company's 2017 outlook was slightly better than our estimates. The shares offer about 13% upside to our DCF-based target price. We characterize our long-term assumptions in our model as optimistic. However, we recognize that the company has a good track record of capital deployment and completing acquisitions which help to augment growth." (2/22/2017)

Some companies that are related to HealthStream include China Cord Blood Corporation (CO), Community Health Systems (CYH), Kindred Healthcare (KND), American Renal Associates Holdings (ARA), Georgia Healthcare Group PLC (GHG), Cambian Group PLC (CMBN), Concord Medical Services Holdings Limited (CCM), Nobilis Health Corp (HLTH), The Joint Corp. (JYNT), Cancer Genetics (CGIX), Streamline Health Solutions (STRM), Air Methods Corp (AIRM), Surgical Care Affiliates (SCAI) and TeamHealth Holdings (TMH).

HealthStream's management team includes the folowing people:

• Robert A. Frist Jr., Chairman of the Board, President, Chief Executive Officer
• Gerard M. Hayden Jr., Chief Financial Officer, Senior Vice President
• J. Edward Pearson Jr., Chief Operating Officer, Senior Vice President
• Jeffrey Cunningham, Senior Vice President, Chief Technology Officer
• Jeffery S. Doster, Senior Vice President, Chief Information Officer
• Michael Sousa, Senior Vice President and President - Echo, Inc
• Thompson S. Dent, Lead Independent Director
• Frank E. Gordon, Independent Director
• C. Martin Harris M.D., Independent Director
• Jeffrey L. McLaren, Independent Director

HealthStream's stock is owned by a variety of of institutional and retail investors. Top institutional investors include FMR LLC (14.85%), Vanguard Group Inc. (7.29%), Riverbridge Partners LLC (6.52%), Conestoga Capital Advisors LLC (4.11%), Pembroke Management LTD (3.97%) and Dimensional Fund Advisors LP (3.72%). Company insiders that own HealthStream stock include Jeffrey Doster, Jeffrey L Mclaren, Michael Sousa and Tate Deborah Taylor. View Institutional Ownership Trends for HealthStream.

HealthStream's stock was sold by a variety of institutional investors in the last quarter, including Teachers Advisors LLC, Conestoga Capital Advisors LLC, First Light Asset Management LLC, Riverbridge Partners LLC, Royce & Associates LP, Thomson Horstmann & Bryant Inc., Bank of New York Mellon Corp and Goldman Sachs Group Inc.. View Insider Buying and Selling for HealthStream.

HealthStream's stock was purchased by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Pier Capital LLC, Pembroke Management LTD, FMR LLC, Vanguard Group Inc., Ameriprise Financial Inc., Adams Diversified Equity Fund Inc. and Northern Trust Corp. View Insider Buying and Selling for HealthStream.

Shares of HealthStream can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of HealthStream stock can currently be purchased for approximately $23.11.